Skip to main content
. 2012 May 30;2(3):e001048. doi: 10.1136/bmjopen-2012-001048

Figure 2.

Figure 2

Estimated mortality rates by socioeconomic quintile (allowing socioeconomic quintile to vary by follow-up) and the HR between the most deprived versus the most affluent patients within 12 months of diagnosis by tumour subgroups using flexible parametric models. (A) Early-stage non-small-cell lung cancer (NSCLC) (mortality rate). (B) Stage III disease (mortality rate). (C) Advanced disease or small-cell lung cancer (SCLC) (mortality rate). (D) Early-stage NSCLC (HR). (E) Stage III disease (HR). (F) Advanced disease or SCLC (HR).